Perpetua Medical AB (publ) (STO:PERP.B)
Sweden
· Delayed Price · Currency is SEK 3.630
-0.110 (-2.94%)
Mar 9, 2026, 1:54 PM CET
Perpetua Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 14.56 | 6.94 | 9.94 | 10.11 | 8.82 | Upgrade
|
| Other Revenue | 0 | - | - | - | - | Upgrade
|
| Revenue | 14.56 | 6.94 | 9.94 | 10.11 | 8.82 | Upgrade
|
| Revenue Growth (YoY) | 109.84% | -30.16% | -1.76% | 14.73% | 363.72% | Upgrade
|
| Cost of Revenue | 6.96 | 3.8 | 4.09 | 3.47 | 2.89 | Upgrade
|
| Gross Profit | 7.6 | 3.14 | 5.85 | 6.65 | 5.93 | Upgrade
|
| Selling, General & Admin | 14.89 | 10.94 | 23.78 | 25.56 | 19.37 | Upgrade
|
| Other Operating Expenses | -11.83 | -5.66 | 0.38 | -0.19 | -0.14 | Upgrade
|
| Operating Expenses | 5.56 | 5.6 | 24.34 | 25.76 | 19.61 | Upgrade
|
| Operating Income | 2.04 | -2.46 | -18.49 | -19.11 | -13.68 | Upgrade
|
| Interest Expense | -0.7 | -0.08 | -0.07 | -0.13 | -0.15 | Upgrade
|
| Interest & Investment Income | 0.08 | 0.29 | 0.29 | 0.07 | 0.12 | Upgrade
|
| Earnings From Equity Investments | -0.23 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0 | - | Upgrade
|
| EBT Excluding Unusual Items | 1.19 | -2.24 | -18.28 | -19.16 | -13.71 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.04 | - | - | - | Upgrade
|
| Pretax Income | 1.19 | -2.2 | -18.28 | -19.16 | -13.71 | Upgrade
|
| Income Tax Expense | -0.02 | 0.18 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | 1.22 | -2.38 | -18.28 | -19.16 | -13.71 | Upgrade
|
| Minority Interest in Earnings | 1.24 | -0.09 | - | - | - | Upgrade
|
| Net Income | 2.45 | -2.47 | -18.28 | -19.16 | -13.71 | Upgrade
|
| Net Income to Common | 2.45 | -2.47 | -18.28 | -19.16 | -13.71 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 4 | 2 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 4 | 2 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 6.46% | 145.32% | 153.20% | 20.61% | 20.91% | Upgrade
|
| EPS (Basic) | 0.54 | -0.58 | -10.56 | -28.03 | -24.18 | Upgrade
|
| EPS (Diluted) | 0.54 | -0.58 | -10.56 | -28.03 | -24.18 | Upgrade
|
| Free Cash Flow | -6.53 | -7.03 | -16.41 | -19.65 | -15.84 | Upgrade
|
| Free Cash Flow Per Share | -1.45 | -1.66 | -9.48 | -28.74 | -27.94 | Upgrade
|
| Gross Margin | 52.21% | 45.27% | 58.85% | 65.72% | 67.26% | Upgrade
|
| Operating Margin | 14.04% | -35.39% | -186.11% | -188.94% | -155.22% | Upgrade
|
| Profit Margin | 16.84% | -35.64% | -183.94% | -189.48% | -155.54% | Upgrade
|
| Free Cash Flow Margin | -44.87% | -101.27% | -165.16% | -194.31% | -179.68% | Upgrade
|
| EBITDA | 4.55 | -2.13 | -18.31 | -18.72 | -13.3 | Upgrade
|
| EBITDA Margin | 31.21% | -30.73% | -184.31% | -185.10% | -150.87% | Upgrade
|
| D&A For EBITDA | 2.5 | 0.32 | 0.18 | 0.39 | 0.38 | Upgrade
|
| EBIT | 2.04 | -2.46 | -18.49 | -19.11 | -13.68 | Upgrade
|
| EBIT Margin | 14.04% | -35.39% | -186.11% | -188.94% | -155.22% | Upgrade
|
| Revenue as Reported | 26.51 | 14.15 | 9.98 | 10.42 | 9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.